Genetic and Molecular Analysis of Mouse Mutants with Congenital Heart Defects
先天性心脏缺陷小鼠突变体的遗传和分子分析
基本信息
- 批准号:7789463
- 负责人:
- 金额:$ 39.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:Atrial Heart Septal DefectsCardiacCarrier ProteinsCellsComplementCongenital Heart DefectsDefectDevelopmentEmbryoErinaceidaeEventGenesGeneticGoalsGrantGrowthHeartHeart AtriumHeart Septal DefectsHumanLaboratoriesLightMapsMolecularMolecular AnalysisMutant Strains MiceMutationPathway interactionsPhenotypePositioning AttributeProteinsPulmonary CirculationReagentRoleSignal TransductionSpecific qualifier valueStem cellsTransgenic OrganismsWorkbasebody systemcongenital heart disordermutantnovelpositional cloningprogenitorpublic health relevancesmoothened signaling pathwaytranscription factor
项目摘要
DESCRIPTION (provided by applicant): Atrial septation is a critical step in separating the systemic and pulmonary circulations in tetrapods and atrial septal defects are among the most common forms of human congenital heart disease (CHD). The objective of this project is to investigate the cellular and molecular mechanisms required for atrial septation and atrial septal progenitor cell specification. The canonical view of atrial septation is based on intracardiac morphogenetic events. However, recent work in our laboratory and others has engendered a novel paradigm for atrial septation, based on contributions from the second heart field (Mommersteeg et al., 2006; Snarr et al., 2007b; Goddeeris et al., 2008). We have identified a subset of cardiac progenitor cells specific for the atrial septum. Hedgehog signaling in the posterior second heart field marks atrial septal progenitors. These findings imply that atrial septum vs. non-septum cell fate is distinguished at the level of progenitor cell specification rather than by positional information acquired subsequently within the developing atrium. The molecular mechanisms by which these newly characterized progenitor cells are specified and generate the atrial septum are currently unknown. Here, we propose an integrative approach using both forward and reverse genetics to build a molecular pathway required for atrial septation and investigate the specification of atrial septal progenitors. Our specific aims are to (1) Analyze the specification, proliferation, and survival of atrial septal progenitors in wild-type and Hedgehog signaling mutant embryos; (2) Analyze atrial septal progenitors and Hh signaling in cac2 mutant mice; and (3) Identify the molecular basis of cac2, a novel gene required for atrial septation. A greater understanding of the molecular basis of atrial septal progenitor cell specification and function will be delivered at the end of the granting period. This work will contribute to an ongoing paradigm shift in our understanding of the ontogeny of cardiac septal defects. PUBLIC HEALTH RELEVANCE: Atrial septation is a critical step in separating the systemic and pulmonary circulations in tetrapods and atrial septal defects are among the most common forms of human congenital heart disease. The objective of this project is to gain a better understanding of atrial septal progenitor cell specification and function. The long- term goal of this work is to understand the ontogeny of atrial septal defects.
描述(申请人提供):房间隔是分离四足动物体肺循环的关键步骤,房间隔缺陷是人类先天性心脏病(CHD)最常见的形式之一。本项目的目的是研究房间隔分离和房间隔祖细胞规范所需的细胞和分子机制。房间隔的标准观点是基于心脏内的形态发生事件。然而,我们实验室和其他实验室最近的工作已经产生了一种新的范例,基于第二心场的贡献(Mommersteig等人,2006年;Snarr等人,2007b;Goddeeris等人,2008年)。我们已经确定了房间隔特异的心脏祖细胞亚群。第二心后区的Hedgehog信号标志着房间隔祖细胞。这些发现表明,房间隔和非间隔细胞的命运是在祖细胞规格的水平上区分的,而不是通过随后在发育中的心房内获得的位置信息来区分的。这些新鉴定的前体细胞被指定并产生房间隔的分子机制目前尚不清楚。在这里,我们提出了一种综合的方法,使用正向和反向遗传学来构建房间隔分离所需的分子通路,并研究房间隔祖细胞的特性。我们的具体目标是(1)分析房间隔祖细胞在野生型和Hedgehog信号突变胚胎中的特性、增殖和存活;(2)分析CaC2突变小鼠的房间隔祖细胞和HH信号;以及(3)确定房间隔形成所需的新基因CaC2的分子基础。在授权期结束时,将对房间隔祖细胞规格和功能的分子基础有更深入的了解。这项工作将有助于我们对心脏间隔缺陷个体发育的理解发生正在进行的范式转变。与公共卫生相关:房间隔是分离四足动物体循环和肺循环的关键步骤,房间隔缺陷是人类先天性心脏病最常见的形式之一。本项目的目的是为了更好地了解房间隔祖细胞的特性和功能。这项工作的长期目标是了解房间隔缺陷的个体发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivan Paul Moskowitz其他文献
Ivan Paul Moskowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivan Paul Moskowitz', 18)}}的其他基金
A heterochronic model for birth defects in Down Syndrome
唐氏综合症出生缺陷的异时模型
- 批准号:
10658360 - 财政年份:2023
- 资助金额:
$ 39.05万 - 项目类别:
Evaluation of Hedgehog signaling-dependent heart development in a mouse model of Down Syndrome
唐氏综合症小鼠模型中刺猬信号依赖性心脏发育的评估
- 批准号:
10747227 - 财政年份:2022
- 资助金额:
$ 39.05万 - 项目类别:
Gene Expression Networks for Human Cardiac Differentiation in Down Syndrome
唐氏综合症人类心脏分化的基因表达网络
- 批准号:
10251345 - 财政年份:2020
- 资助金额:
$ 39.05万 - 项目类别:
Gene Expression Networks for Human Cardiac Differentiation in Down Syndrome
唐氏综合症人类心脏分化的基因表达网络
- 批准号:
10057128 - 财政年份:2020
- 资助金额:
$ 39.05万 - 项目类别:
The molecular basis of cardiac differentiation control
心脏分化控制的分子基础
- 批准号:
10237139 - 财政年份:2019
- 资助金额:
$ 39.05万 - 项目类别:
Gene Regulatory Non-Coding RNAs in the Human Heart
人类心脏中的基因调控非编码 RNA
- 批准号:
10223926 - 财政年份:2019
- 资助金额:
$ 39.05万 - 项目类别:
Gene Regulatory Non-Coding RNAs in the Human Heart
人类心脏中的基因调控非编码 RNA
- 批准号:
10460639 - 财政年份:2019
- 资助金额:
$ 39.05万 - 项目类别:
The molecular basis of cardiac differentiation control
心脏分化控制的分子基础
- 批准号:
9766033 - 财政年份:2019
- 资助金额:
$ 39.05万 - 项目类别:
The molecular basis of cardiac differentiation control
心脏分化控制的分子基础
- 批准号:
10460174 - 财政年份:2019
- 资助金额:
$ 39.05万 - 项目类别:
Gene Regulatory Non-Coding RNAs in the Human Heart
人类心脏中的基因调控非编码 RNA
- 批准号:
9803245 - 财政年份:2019
- 资助金额:
$ 39.05万 - 项目类别:
相似海外基金
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
- 批准号:
10749672 - 财政年份:2024
- 资助金额:
$ 39.05万 - 项目类别:
Towards widespread use of cardiac MRI using new affordable low magnetic field (0.55T) MRI scanner and AI
使用新型经济实惠的低磁场 (0.55T) MRI 扫描仪和 AI 实现心脏 MRI 的广泛使用
- 批准号:
2904562 - 财政年份:2024
- 资助金额:
$ 39.05万 - 项目类别:
Studentship
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
- 批准号:
MR/Y003594/1 - 财政年份:2024
- 资助金额:
$ 39.05万 - 项目类别:
Research Grant
Using Novel Machine Learning Methods to Personalize Strategies for Prevention of Persistent AKI after Cardiac Surgery
使用新颖的机器学习方法制定个性化策略,预防心脏手术后持续性 AKI
- 批准号:
10979324 - 财政年份:2024
- 资助金额:
$ 39.05万 - 项目类别:
Investigating the mechanosensitive interplays between genetic control and self-organisation during the emergence of cardiac tissue curvature
研究心脏组织曲率出现过程中遗传控制和自组织之间的机械敏感性相互作用
- 批准号:
BB/Y00566X/1 - 财政年份:2024
- 资助金额:
$ 39.05万 - 项目类别:
Research Grant
Novel minimally-invasive in-situ 3D bioprinting platform for cardiac regeneration
用于心脏再生的新型微创原位3D生物打印平台
- 批准号:
EP/X027287/2 - 财政年份:2024
- 资助金额:
$ 39.05万 - 项目类别:
Fellowship
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 39.05万 - 项目类别:
Standard Grant
Postoperative reduction in thrombin generation in cardiac surgery: pathogenesis and evaluation
心脏手术术后凝血酶生成减少:发病机制和评估
- 批准号:
23H03001 - 财政年份:2023
- 资助金额:
$ 39.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for cardiac fibrosis using a cell removal vaccine
使用细胞去除疫苗开发治疗心脏纤维化的新疗法
- 批准号:
23K07504 - 财政年份:2023
- 资助金额:
$ 39.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 39.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)